First Trust Advisors LP Has $23.68 Million Stock Holdings in Humana Inc. (NYSE:HUM)

First Trust Advisors LP increased its position in Humana Inc. (NYSE:HUM - Free Report) by 78.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 93,328 shares of the insurance provider's stock after acquiring an additional 41,070 shares during the period. First Trust Advisors LP owned approximately 0.08% of Humana worth $23,678,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Transcend Capital Advisors LLC increased its holdings in shares of Humana by 399.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after acquiring an additional 2,914 shares during the period. FNY Investment Advisers LLC increased its stake in Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after buying an additional 26,856 shares during the period. Retirement Systems of Alabama increased its stake in Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after buying an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Humana by 7.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after buying an additional 65,735 shares during the period. Finally, Secure Asset Management LLC acquired a new position in Humana during the 4th quarter valued at about $244,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Stock Down 1.6 %

Shares of HUM stock traded down $4.29 during trading on Tuesday, hitting $258.91. 2,471,973 shares of the company were exchanged, compared to its average volume of 1,749,990. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market capitalization of $31.25 billion, a price-to-earnings ratio of 26.02, a P/E/G ratio of 2.05 and a beta of 0.62. The business's 50-day simple moving average is $266.31 and its 200 day simple moving average is $270.84. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.37%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is currently 35.58%.

Analyst Ratings Changes

Several equities analysts have commented on HUM shares. JPMorgan Chase & Co. lowered their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. StockNews.com raised shares of Humana from a "hold" rating to a "buy" rating in a research note on Monday, April 7th. Morgan Stanley lowered their target price on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Finally, Barclays lifted their price objective on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research note on Friday, April 11th. Seventeen analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $284.90.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.